Pahayahay, Novie .
HRN: 20-11-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2023
04/03/2023
IV
500mg
Q 8hrs X 6 Doses
S/P Cesarean Section
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes